SCHEMBL29489795

SCHEMBL29489795

[Ir+3].c1ccc2c(c1)c1ccccc1c1nccnc21.c1ccc2c(c1)c1ccccc1c1nccnc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.50
HSP90AA1 P07900 2/20 0.50
NPC1 O15118 1/20 0.50
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
ALDH1A1 P00352 1/20 0.43
PARP1 P09874 3/20 0.42
CCR1 P32246 5/20 0.40
CCR8 P51685 5/20 0.40
CCR5 P51681 3/20 0.40
DHFR P00374 1/20 0.38
LMNA P02545 3/20 0.38
MAPT P10636 3/20 0.38
KDM4E B2RXH2 2/20 0.38
GMNN O75496 1/20 0.38
TP53 P04637 1/20 0.38
MMP2 P08253 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
MMP9 P14780 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL713323 0.97 L3MBTL1 (0.52) L3MBTL1HSP90AA1NPC1MEN1KMT2A
SCHEMBL30863911 0.97 L3MBTL1 (0.52) L3MBTL1HSP90AA1NPC1MEN1KMT2A
SCHEMBL15251334 0.94 L3MBTL1 (0.50) L3MBTL1HSP90AA1NPC1MEN1KMT2A
SCHEMBL18816320 0.91 L3MBTL1 (0.52) L3MBTL1HSP90AA1NPC1MEN1KMT2A
Naphthalene SCHEMBL6762706 0.89 ALDH1A1 (0.50) L3MBTL1HSP90AA1NPC1MEN1KMT2A
SCHEMBL4993117 0.88 HSP90AA1 (0.64) L3MBTL1HSP90AA1NPC1ALDH1A1PARP1
SCHEMBL10025832 0.87 L3MBTL1 (0.44) L3MBTL1HSP90AA1NPC1MEN1KMT2A
SCHEMBL29849953 0.85 HSP90AA1 (0.67) L3MBTL1HSP90AA1NPC1MEN1KMT2A
SCHEMBL4009364 0.85 HSP90AA1 (0.67) L3MBTL1HSP90AA1NPC1MEN1KMT2A
SCHEMBL21298469 0.85 L3MBTL1 (0.43) L3MBTL1HSP90AA1NPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12538704-B2 4H-imidazo[1,2-a]imidazoles for electronic applications UDC IRELAND LIMITED (IE) 2026-01-27 US disclosed
US-11744152-B2 Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications UDC IRELAND LIMITED (IE) 2023-08-29 US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
US-20230090208-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications UDC IRELAND LTD (IE) 2023-03-23 US disclosed
US-11605790-B2 Monosubstituted diazabenzimidazole carbene metal complexes for use in organic light emitting diodes UDC IRELAND LIMITED (IE) 2023-03-14 US disclosed
US-11505561-B2 Organic light emitting device and materials for use in same IDEMITSU KOSAN CO., LTD. (JP) 2022-11-22 US disclosed
US-11450812-B2 4H-imidazo[1,2-a]imidazoles for electronic applications UDC IRELAND LIMITED (IE) 2022-09-20 US disclosed
EP-3356369-B1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING TRIAZINE GROUPS FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO (JP) 2022-05-04 EP disclosed
US-11279709-B2 Specifically substituted aza-dibenzofurans and aza-dibenzothiophenes for organic electronic devices IDEMITSU KOSAN CO., LTD. (JP) 2022-03-22 US disclosed
EP-3640252-B1 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS UDC IRELAND LTD (IE) 2022-03-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11450812-B2 4H-imidazo[1,2-a]imidazoles for electronic applications PAH, NISCH, KCNH1 L3MBTL1 4627/4885HSP90AA1 1402/4885NPC1 3851/4885
US-12538704-B2 4H-imidazo[1,2-a]imidazoles for electronic applications RIF1, NR2E1, NR3C1 L3MBTL1 2761/4885HSP90AA1 2636/4885NPC1 3180/4885
US-11279709-B2 Specifically substituted aza-dibenzofurans and aza-dibenzothiophenes for organic electronic devices CDY1; CDY1B, CDYL, CBX8 L3MBTL1 1094/4885HSP90AA1 4632/4885NPC1 3768/4885
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 L3MBTL1 1618/4885HSP90AA1 4581/4885NPC1 2663/4885
US-20230090208-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications PAH, NISCH, KCNH1 L3MBTL1 4627/4885HSP90AA1 1402/4885NPC1 3851/4885
US-11605790-B2 Monosubstituted diazabenzimidazole carbene metal complexes for use in organic light emitting diodes DDT, OCIAD1, OCIAD2 L3MBTL1 1063/4885HSP90AA1 4853/4885NPC1 4696/4885
US-11505561-B2 Organic light emitting device and materials for use in same CYBA, CLTB, XPO6 L3MBTL1 2826/4885HSP90AA1 4185/4885NPC1 2277/4885
US-11744152-B2 Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications PAICS, EIF4A1, ECI1 L3MBTL1 3230/4885HSP90AA1 2530/4885NPC1 4384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.